COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,003 Articles (22,627 medRxiv, 8,376 bioRxiv)

Most recent first Previous |  Page 785: Articles 7841-7850  | Next

Transcriptome and DNA methylome analysis of peripheral blood samples reveals incomplete restoration and transposable element activation after 3-month recovery of COVID-19
Yin, Y., Liu, X.-z., Tian, Q., Fan, Y.-x., Ye, Z., Meng, T.-q., Wei, G.-h., Xiong, C.-l., Li, H., He, X., Zhou, L.
10.1101/2022.04.19.22274029 — Posted: 2022-04-23
Immune and pathophysiologic profiling of antenatal COVID-19 in the GIFT cohort: A Singaporean case-control study.
Gu, Y., Low, J. M., Tan, J. S. Y., Ng, M. S. F., Ng, L. F. P., Shunmuganathan, B. D., Gupta, R., MacAry, P. A., Amin, Z., Lee, L. Y., Lian, D. W. Q., Shek, L. P.-C., Zhong, Y., Wang, L. W.
10.1101/2022.04.19.22273864 — Posted: 2022-04-23
Estimating the distribution of COVID-19-susceptible, -recovered, and -vaccinated individuals in Germany up to April 2022
Maier, B. F., Rose, A. H., Burdinski, A., Klamser, P., Neuhauser, H., Wichmann, O., Schaade, L., Wieler, L. H., Brockmann, D.
10.1101/2022.04.19.22274030 — Posted: 2022-04-23
Estimation of the Ascertainment Bias in Covid Case Detection During the Omicron Wave
Elbanna, A.
10.1101/2022.04.22.22274198 — Posted: 2022-04-23
Snotwatch COVID-Toes: An ecological study of chilblains and COVID-19 diagnoses in Victoria, Australia
Sawires, R., Pearce, C., Fahey, M., Clothier, H., Gardner, K., Buttery, J.
10.1101/2022.04.21.22274140 — Posted: 2022-04-22
Regional replacement of SARS-CoV-2 variant BA.1 with BA.2 as observed through wastewater surveillance
Boehm, A., Duong, D., Hughes, B., Wolfe, M. K., White, B., Chan-Herur, V.
10.1101/2022.04.22.22274160 — Posted: 2022-04-22
Epidemiological investigation of the COVID-19 outbreak in Vellore district in South India using Geographic Information Surveillance (GIS)
Murugesan, M., Venkatesan, P., Kumar, S., Thangavelu, P., Rose, W., John, J., Mohan, V. R., Rupali, P.
10.1101/2022.04.21.22274138 — Posted: 2022-04-22
COVID-19 patients share common, corticosteroid-independent features of impaired host immunity to pathogenic molds
Tappe, B., Lauruschkat, C. D., Strobel, L., Pantaleon Garcia, J., Kurzai, O., Rebhan, S., Kraus, S., Pfeuffer-Jovic, E., Bussemer, L., Possler, L., Held, M., Huenniger, K., Kniemeyer, O., Schaeuble, S., Brakhage, A., Panagiotou, G., White, L. P., Einsele, H., Loeffler, J., Wurster, S.
10.1101/2022.04.21.22274082 — Posted: 2022-04-22
Usage and awareness of antiviral medications for COVID-19
Kojima, N., Klausner, J. D.
10.1101/2022.04.21.22274155 — Posted: 2022-04-22
Effectiveness of the neutralizing antibody sotrovimab among high-risk patients with mild to moderate SARS-CoV-2 in Qatar
Zaqout, A., Almaslamani, M. A., Chemaitelly, H., Hashim, S. A., Ittaman, A., Alimam, A., Rustom, F., Daghfal, J., Abukhattab, M., AlMukdad, S., Kaleeckal, A. H., Latif, A. N., Butt, A. A., Bertollini, R., Al-Khal, A., Omrani, A. S., Abu-Raddad, L. J.
10.1101/2022.04.21.22274060 — Posted: 2022-04-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).